Grand Research Store

Global Next Generation Cancer Diagnostics Market Size Study, By Technology,By Application,By Cancer Type and Regional Forecasts, 2017-2025

Press Release   •   Apr 17, 2018 15:37 IST

Global Next Generation Cancer Diagnostics Market to reach USD 14.5 billion by 2025.

Global Next Generation Cancer Diagnostics Market is valued approximately USD 5.8 billion in 2016 and is expected to grow at 16.5% CAGR during the forecast period. Owing to the early diagnosis and more précised prognosis of various types of cancer, the next generation cancer diagnostics are gaining faster adoption. Moreover, increasing cases of oncology and advancements in genomics research are primarily driving the market growth.

Download FREE Sample of this Report @

The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and subsegment of the global infertility treatment market are given below:


  • NGSbased cancer diagnostics
  • qPCR & Multiplexing
  • Labon a chip LOAC & Reverse TranscriptasePCR RTPCR
  • Protein microarraysbased cancer diagnostics
  • DNA microarraysbased cancer diagnostics


  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Others


  • Biomarker Development
  • CTC Analysis
  • Proteomic Analysis
  • Epigenetic Analysis
  • Genetic Analysis


  • Therapeutic Monitoring
  • Companion Diagnostics
  • Prognostic Diagnostics
  • Cancer Screening
  • Risk Analysis


North America

o U.S.

o Canada


o UK

o Germany

o France

Asia Pacific

o China

o India

o Japan

Rest of the World

Furthermore, the years considered for the study are as follows:

  • Historical year 2015
  • Base year – 2016
  • Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are; Novartis AG, F. HoffmannLa Roche Ltd, Koninklijke Philips N.V., Abbott , GE Healthcare , Thermo Fisher Scientific, Inc.

Target Audience of the Next Generation Cancer Diagnostics Market Study

  • Key Consulting Companies & Advisors
  • Large, mediumsized, and small enterprises
  • Venture capitalists
  • ValueAdded Resellers VARs
  • Thirdparty knowledge providers
  • Investment bankers
  • Investors
Get the Complete Report & TOC @

Table of content

Chapter 1. Research Methodology
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
Chapter 2. Global Next Generation Cancer Diagnostics Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
Chapter 3. Executive Summary
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 20152025 USD Billion/Million
Chapter 4. Global Next Generation Cancer Diagnostics Industry Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global Next Generation Cancer Diagnostics Market by Technology
5.1. Market Snapshot
5.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
5.2.1. NGSbased cancer diagnostics Market estimates & forecasts, 20152025 USD Billion/Million Regional breakdown estimates & forecasts, 20152025 USD Billion/Million

If You Have Any Question Related To This Report Contact Us @

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885

Follow Us On linkedin :-